HearTwave® II Microvolt T-Wave Alternans™ SystemThe HearTwave II system is a state-of-the-art stress testing platform that includes Cambridge Heart’s proprietary Microvolt T-Wave Alternans^tm (MTWA) option, the only Medicare-reimbursable MTWA test on the market.

Microvolt T-Wave Alternans (MTWA) enhances stress testing by incorporating a non-invasive, clinically-proven, reimbursable test that can help identify patients at risk for Sudden Cardiac Arrest (SCA).

This comprehensive solution enables you to assess both ischemic and arrhythmic risk, allowing you to determine the best overall risk management strategy for your patients.

With the HearTwave II, Cambridge Heart offers you:

• MTWA -- a simple, non-invasive test that can easily become part of your stress regimen for nuclear, echo and standard treadmill procedures.
• A state-of-the-art stress system with patented high-fidelity trace quality, patented diagnostic ECG grid, customized protocols, full disclosure, network connectivity, wireless and laser printer options, and compatibility with most treadmills, NIBP and echo systems
• EMR support including PDF, HL7 and DICOM data formats to streamline clinical workflow

• HearTwave II Brochure
• HearTwave II Specifications
• HearTwave II Options & Accessories

To order in the U.S., contact Cambridge Heart Customer Service at:

• 888.226.9283 (Option #2)
• Via This e-mail address is being protected from spambots. You need JavaScript enabled to view it

For ordering information outside the U.S., contact one of our International Distributors.